Heptovir (Lamivudine)
Brand: Heptovir
Active Ingredient(s): Lamivudine
Strength: 5 mg / mL
Pack Size: 240 mL Oral Solution
Store at room temperature.
DIN: 02239194
Manufacturer: GlaxoSmithKline (Canada)
Alternatives: 3TC
$137.43
*A valid prescription is required for Rx items.
Description
Heptovir (Lamivudine) is an antiviral agent. It is typically used to treat people with chronic hepatitis B (liver disease caused by a virus) infection and evidence of hepatitis B virus replication (reproduction). It may also have other uses.
Additional information
Heptovir (Lamivudine) is typically used as four teaspoons (20 mL) of oral solution. However, your doctor or pharmacist may have suggested a different schedule that is more appropriate for you. Important: Follow the instructions on the label. Do not use more of this product, or more often, than prescribed. If you forget a dose, contact your pharmacist. Administer with or without food. Use a measuring device (e.g., an oral syringe or a measuring spoon) that is marked for accurate dosing. WARNING: Severe worsening of hepatitis (liver inflammation) has occurred in patients who have stopped taking anti-hepatitis B therapy (including HEPTOVIR). Your doctor will monitor your condition in this case and may resume therapy. HEPTOVIR is not recommended during the first 3 months of pregnancy. Do not stop treatment with HEPTOVIR without your doctor’s advice. Your doctor will advise whether you should breastfeed your baby while you are taking HEPTOVIR. in patients with unrecognized or untreated HIV (the virus that can cause acquired immunodeficiency syndrome (AIDS)), HIV-resistance may develop when treated with this drug (when the treatment does not work anymore). In addition to its desired action, Heptovir (Lamivudine) may cause some side effects, notably: It may cause water retention, vomiting, diarrhea, nausea. It may cause low blood pressure, cold extremities, difficulty sleeping. Contraindications: Hypersensitivity to lamivudine or any component of the formulation. Taking Heptovir (Lamivudine) during pregnancy may be harmful for the baby. Women of childbearing potential should use an effective contraceptive method. There is no available data regarding the harm of Heptovir (Lamivudine) for the fetus, therefore it is not recommended to use it. If you're planning a pregnancy or become pregnant or breastfeeding, contact your family doctor. A treatment with Heptovir (Lamivudine) requires regular monitoring by a doctor. Be sure to see your doctor for all regularly scheduled appointments.Heptovir (Lamivudine)
Warning
Each person may react differently to a treatment. If you think this medication may be causing side effects (including those described here, or others), talk to your doctor or pharmacist. He or she can help you to determine whether or not the medication is the source of the problem.
There are no reviews yet.
Reviews